|Bid||0.00 x 900|
|Ask||0.00 x 900|
|Day's Range||1.35 - 1.44|
|52 Week Range||1.12 - 8.67|
|Beta (3Y Monthly)||3.23|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Yield10 Bioscience Inc’s (NASDAQ:YTEN): Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing disruptive technologies for enhancing crop yield in the United States and Canada. The US$12.9m market-cap company’sRead More...
Assessing Yield10 Bioscience Inc’s (NASDAQ:YTEN) performance as a company requires looking at more than just a years’ earnings data. Below, I will run you through a simple sense check toRead More...
Examining Yield10 Bioscience Inc’s (NASDAQ:YTEN) past track record of performance is a useful exercise for investors. It allows us to reflect on whether the company has met or exceed expectations,Read More...
Yield10 Bioscience Inc (NASDAQ:YTEN) shares are shooting up 268% faster than Jack's magic bean sparking right into a giant beanstalk, thanks to today's news of a granted non-exclusive research license to Monsanto Company to evaluate the agricultural bioscience company's novel algal genes C3003 and C3004. Specifically, Monsanto intends to study these two yield traits within the scope of its soybean pipeline as a larger game plan to enhance plant yields. The name of the game for Yield10 is all about boosting seed yield as well as oil content in oilseed crops, which includes the likes of canola.
Categories: Yahoo FinanceGet free summary analysis Yield10 Bioscience, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Yield10 Bioscience, Inc. – Westlake Chemical Corporation, PolyOne Corporation, A. Schulman, Inc., Trinseo SA, DowDuPont Inc., BioAmber, Inc., Abbott Laboratories, Braskem S.A. Sponsored ADR Pfd Class A and ... Read more (Read more...)
Yield10 Bioscience Inc (NASDAQ:YTEN), a USD$7.79M small-cap, is a chemicals company operating in an industry which is sensitive to changes in the business cycle, as it supplies materials for constructionRead More...
In this analysis, my focus will be on developing a perspective on Yield10 Bioscience Inc’s (NASDAQ:YTEN) latest ownership structure, a less discussed, but important factor. Ownership structure of a companyRead More...